Based upon strong SOD2 immunoreactivity in MMs in contrast to adenocarcinomas [43], and low SOD2 levels in healthy human pleural mesothelium compared to high endogenous levels in MM lines [44], SOD2 has been proposed as a diagnostic marker for MM. The gene discussed is SOD2; the disease is Miyoshi myopathy.